↓ Skip to main content

Dapagliflozin in patients with COVID-19: truth or dare

Overview of attention for article published in The Lancet Diabetes & Endocrinology, July 2021
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (84th percentile)

Mentioned by

twitter
23 X users
facebook
1 Facebook page

Citations

dimensions_citation
3 Dimensions

Readers on

mendeley
9 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Dapagliflozin in patients with COVID-19: truth or dare
Published in
The Lancet Diabetes & Endocrinology, July 2021
DOI 10.1016/s2213-8587(21)00206-0
Pubmed ID
Authors

Xavier Rossello, Francisca Caimari

X Demographics

X Demographics

The data shown below were collected from the profiles of 23 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 9 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 9 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 22%
Student > Bachelor 2 22%
Professor 1 11%
Unknown 4 44%
Readers by discipline Count As %
Medicine and Dentistry 4 44%
Unknown 5 56%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 12. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 05 February 2024.
All research outputs
#3,064,379
of 25,392,582 outputs
Outputs from The Lancet Diabetes & Endocrinology
#1,224
of 2,140 outputs
Outputs of similar age
#69,912
of 445,488 outputs
Outputs of similar age from The Lancet Diabetes & Endocrinology
#37
of 46 outputs
Altmetric has tracked 25,392,582 research outputs across all sources so far. Compared to these this one has done well and is in the 87th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 2,140 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 76.3. This one is in the 42nd percentile – i.e., 42% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 445,488 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 84% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one is in the 19th percentile – i.e., 19% of its contemporaries scored the same or lower than it.